An interventional study of New, improved smoking cessation management module in Delivery of Health Care and Smoking Cessation, sponsored by McMaster University. Status unknown at 2 sites in Canada. Per ClinicalTrials.gov, last updated 2009-10-29.
Sponsored by McMaster University · Not applicable, Interventional, and Health services research
This pilot study will determine the feasibility of studying a new smoking cessation management module in an existing chronic disease management system. The new module is intended to help healthcare providers deliver more smoking cessation counselling to their patients.
990 studies on the registry are indexed under Chronic Disease; 178 are open to participants now.
This study's planned enrollment of 10 is below the median of 120 across 722 interventional studies indexed under Chronic Disease.
Browse Chronic Disease studies →McMaster University is the lead sponsor of 720 studies on the registry; 124 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: New, improved smoking cessation management module
The intervention that will be tested is an improved smoking cessation management module in an existing chronic disease management system, P-PROMPT CDMS. This module includes the following components: a) the Patient Care Status and Update Form, b) the smoking registry and c) patient prompts.
Smoker Identifying Cards
Time frame: 3 months post-intervention
Chronic disease management system's activity log
Time frame: monthly post-intervention
Smoking cessation counselling billing codes from physician's remittance advice files
Time frame: monthly post-intervention
This study is status unknown, as verified in Oct 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
McMaster University